Zhu, Hongxu <br/><br/>
Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology.  [electronic resource] 

 -  Scientific reports  05 2018 
 - 7238 p.  digital 
<br/><br/> Publication Type: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-25500-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>Computational Biology<br/>Drugs, Chinese Herbal--therapeutic use<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Regulatory Networks--drug effects<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>Medicine, Chinese Traditional--methods<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Multivariate Analysis<br/>Neovascularization, Pathologic--genetics<br/>PPAR gamma--antagonists & inhibitors<br/>Phosphatidylinositol 3-Kinase--genetics<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Retinoid X Receptors--antagonists & inhibitors<br/>Retrospective Studies<br/>Signal Transduction<br/>Survival Analysis<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>src-Family Kinases--antagonists & inhibitors